Migraine is a complex and disabling neurological disorder characterized by recurrent moderate to severe headaches, typically unilateral and pulsating in nature. It affects approximately 1 billion people worldwide, including 12% of the population in North America and Europe[1]. Understanding the causes and triggers of migraines is critical for effective management and prevention. This article provides a comprehensive overview of the current scientific understanding of migraine causes, covering key aspects such as genetics, brain mechanisms, triggers, and the role of hormones.
Genetic Factors
Migraine has a strong genetic component, with over 80% of migraine patients having a family history of the disorder[2]. Twin studies estimate the heritability of migraine to be around 40-60%[3]. Several susceptibility genes and loci have been identified through genome-wide association studies (GWAS), including genes involved in glutamatergic neurotransmission, synaptic function, and vascular function[4]. However, each individual genetic variant confers only a small increase in risk, suggesting migraine is a complex polygenic disorder. The key genes and pathways implicated so far include[4][5]:
- CACNA1A – encodes a subunit of calcium channels involved in controlling neurotransmitter release. Mutations cause familial hemiplegic migraine.
- ATP1A2 – encodes a sodium-potassium pump involved in ion transport. Mutations cause familial hemiplegic migraine.
- SCN1A – encodes a sodium channel subunit. Variants increase migraine risk.
- LRP1 – encodes a lipoprotein receptor involved in synaptic plasticity and vascular integrity.
- PRDM16 – encodes a transcriptional regulator that controls endothelial and smooth muscle cell function.
- TRPM8 – encodes an ion channel involved in pain signaling pathways.
- TGFBR2 – encodes a TGF-beta receptor with a role in vascular integrity.
- MEF2D – encodes a transcription factor involved in synaptic plasticity.
Overall, the genetic landscape points to dysfunction in ion transport, neurotransmitter release, and vascular integrity as key factors in migraine susceptibility.
Brain Mechanisms
Migraine is now considered primarily a disorder of brain function, rather than solely a vascular disease. Several regions of the brain have been implicated[6]:
- Trigeminovascular system – Key pain pathways consisting of the trigeminal nerve and cranial blood vessels. Activation leads to release of inflammatory neuropeptides like CGRP that promote pain signaling.
- Hypothalamus – Regulates homeostasis and pain modulation. Dysfunction can trigger migraine.
- Brainstem – Contains key nuclei like the periaqueductal gray matter that modulate pain. Implicated in migraine generation.
- Thalamus – Relays sensory signals including pain. Hyperactivity seen during migraine.
- Cortical regions – Processing of sensory stimuli like light, sound, and smell is altered during migraine. The visual cortex shows hyperactivity.
Abnormal cortical excitability and activation of the trigeminovascular system generates the pain, while dysfunction in modulatory circuits of the brainstem and hypothalamus promotes attack progression. Neuroimaging studies confirm unique patterns of brain activity during different migraine phases[6].
Triggers
Migraine attacks may be precipitated by various internal and external triggers in genetically susceptible individuals. Common triggers include[7]:
- Stress – Reported by 80% of patients. Activates fight-or-flight pathways.
- Hormonal changes – Fluctuations during the menstrual cycle trigger menstrual migraine. Also seen during pregnancy and menopause.
- Sleep disturbances – Sleep deprivation and excess sleep can trigger attacks. Disrupts circadian rhythms.
- Dietary – Skipping meals, caffeine withdrawal, alcohol (especially red wine), and certain foods high in amines.
- Sensory stimuli – Bright lights, loud sounds, strong smells. Heightened sensory processing during migraine.
- Weather changes – Barometric pressure changes during storms and altitude changes. Possibly due to effects on blood vessels.
- Physical factors – Intense exercise. May be due to activation of the trigeminovascular system.
Avoiding triggers is an important part of migraine management. However, the underlying brain dysfunction is the primary cause. Triggers likely act by further disrupting already compromised brain pathways in susceptible individuals[8].
Role of Hormones
Hormonal fluctuations precipitate migraine in many women, implicating estrogen signaling in migraine pathology[9]:
- Menstrual migraine occurs in the first few days of the menstrual period when estrogen levels rapidly decline.
- Migraine risk increases after puberty when estrogen levels rise. More prevalent in women after puberty.
- Oral contraceptives and hormone replacement therapy can worsen migraine in some women.
- Pregnancy offers relief to some women as estrogen levels are elevated and stable.
Estrogen modulates neurotransmitter systems like serotonin and CGRP which are involved in migraine. It also increases nitric oxide production which dilates blood vessels. The cyclic withdrawal of estrogen during the menstrual period may render the brain more susceptible to migraine triggers.
Treatments and Prevention
While migraine causes are not fully curable, several treatment approaches help manage symptoms and reduce attack frequency.
Acute Treatments
Medications used to treat acute migraine attacks include[10]:
- Simple analgesics like ibuprofen and acetaminophen.
- Triptans – Serotonin receptor agonists that constrict blood vessels and inhibit pain pathways.
- Anti-nausea medications.
- Ergot alkaloids like ergotamine.
Non-pharmacological options like resting in a dark room, ice packs, and hydration also help alleviate symptoms.
Preventive Treatments
Long-term preventive medications and non-drug approaches include[10]:
- Beta blockers like propranolol and metoprolol.
- Antidepressants such as amitriptyline.
- Anti-seizure drugs like topiramate and valproate.
- OnabotulinumtoxinA injections.
- Nutritional supplements like riboflavin, magnesium, and Coenzyme Q10.
- Relaxation techniques, cognitive behavioral therapy, and trigger avoidance.
- Aerobic exercise.
For menstrual migraine, short-term prevention around the menstrual period using triptans, NSAIDs, or hormones may help[9].
Summing up
In summary, migraine is a neurological disorder with a strong genetic basis and unique patterns of brain dysfunction that generate headaches and associated symptoms. Hormonal fluctuations and environmental triggers can initiate attacks in susceptible individuals. While more research is needed, current evidence points to excitability in pain pathways, dysregulation of homeostasis, and vascular mechanisms as key players in migraine causes. Identifying individual triggers and using acute treatments and preventive strategies helps mitigate the substantial pain and disability imposed by migraine for millions worldwide.
References
[1] GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 May;17(11):954-976.
[2] Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ. 1995 Jan 14;310(6977):141-4.
[3] Mulder EJ, Van Baal C, Gaist D, Kallela M, Kaprio J, Svensson DA, Nyholt DR, Martin NG, MacGregor AJ, Cherkas LF, Boomsma DI, Palotie A. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res. 2003 Oct;6(5):422-31.
[4] Gormley P, Anttila V, Winsvold BS, Palta P, Esko T, Pers TH, Farh KH, Cuenca-Leon E, Muona M, Furlotte NA, Kurth T, Ingason A, McMahon G, Ligthart L, Terwindt GM, Kallela M, Freilinger TM, Ran C, Gordon SG, Stam AH, Steinberg S, Borck G, Koiranen M, Quaye L, Adams HH, Lehtimäki T, Sarin AP, Wedenoja J, Hinds DA, Buring JE, Schürks M, Ridker PM, Hrafnsdottir MG, Stefansson H, Ring SM, Hottenga JJ, Penninx BW, Färkkilä M, Artto V, Kaunisto M, Vepsäläinen S, Malik R, Heath AC, Madden PA, Martin NG, Montgomery GW, Kurki MI, Kals M, Mägi R, Pärn K, Hämäläinen E, Huang H, Byrnes AE, Franke L, Huang J, Stergiakouli E, Lee PH, Sandor C, Webber C, Cader Z, Muller-Myhsok B, Schreiber S, Meitinger T, Eriksson JG, Salomaa V, Heikkilä K, Loehrer E, Uitterlinden AG, Hofman A, van Duijn CM, Cherkas L, Pedersen LM, Stubhaug A, Nielsen CS, Männikkö M, Mihailov E, Milani L, Göbel H, Esserlind AL, Christensen AF, Hansen TF, Werge T, Kaprio J, Aromaa AJ, Raitakari O, Ikram MA, Spector T, Järvelin MR, Metspalu A, Kubisch C, Strachan DP, Ferrari MD, van den Maagdenberg AMJM, Zwart JA, Boomsma DI, Wessman M, Smith GD, Stefansson K, Eriksson N, Dichgans M, Daly MJ, Neale BM, Olesen J, Chasman DI, Nyholt DR, Palotie A; International Headache Genetics Consortium. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016 Aug;48(8):856-66.
[5] Anttila V, Winsvold BS, Gormley P, Kurth T, Bettella F, McMahon G, Kallela M, Malik R, de Vries B, Terwindt G, Medland SE, Todt U, McArdle WL, Quaye L, Koiranen M, Ikram MA, Lehtimäki T, Stam AH, Ligthart L, Wedenoja J, Dunham I, Neale BM, Palta P, Hamalainen E, Schürks M, Rose LM, Buring JE, Ridker PM, Steinberg S, Stefansson H, Jakobsson F, Lawlor DA, Evans DM, Ring SM, Färkkilä M, Artto V, Kaunisto MA, Freilinger T, Schoenen J, Frants RR, Pelzer N, Weller CM, Zielman R, Heath AC, Madden PA, Montgomery GW, Martin NG, Borck G, Göbel H, Heinze A, Heinze-Kuhn K, Williams FM, Hartikainen AL, Pouta A, van den Ende J, Uitterlinden AG, Hofman A, Amin N, Hottenga JJ, Vink JM, Heikkilä K, Alexander M, Muller-Myhsok B, Schreiber S, Meitinger T, Wichmann HE, Aromaa A, Eriksson JG, Traynor BJ, Trabzuni D, Rossin E, Lage K, Jacobs SB, Gibbs JR, Birney E, Kaprio J, Penninx BW, Boomsma DI, van Duijn C, Raitakari O, Jarvelin MR, Zwart JA, Cherkas L, Strachan DP, Kubisch C, Ferrari MD, van den Maagdenberg AM, Dichgans M, Wessman M, Smith GD, Stefansson K, Daly MJ, Nyholt DR, Chasman DI, Palotie A; North American Brain Expression Consortium; UK Brain Expression Consortium. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet. 2013 Aug;45(8):912-7.
[6] Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017 Apr;97(2):553-622.
[7] Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007 Sep;27(9):394-402.
[8] Pavlovic JM, Buse DC, Sollars CM, Haut S, Lipton RB. Trigger factors and premonitory features of migraine attacks: summary of studies. Headache. 2014 Oct;54(10):1670-9.
[9] MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 2004 Jun;3(6):354-61.
[10] Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neuro
